BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 15, 2014
View Archived Issues
Evidence suggests the utility of lncRNAs for preventing cardiac hypertrophy
Read More
AAV-mediated antibody gene delivey protects against malaria
Read More
Celon's PI3Kdelta inhibitor shows high potency and selectivity in vivo
Read More
Eisai and Kyorin enter into agreement for compound library use
Read More
EMD Serono and Accelerated Cure Project partner to optimize treatment for MS
Read More
Altor BioScience and Shenzhen Beike Biotechnology enter into license agreement for ALT-803
Read More
MabVax Therapeutics partners with MSK and Juno Therapeutics
Read More
Seattle Genetics and Genmab enter into new antibody-drug conjugate collaboration
Read More
Flex Pharma raises funds to support clinical candidates
Read More
Shionogi presents results for S-649266 for the treatment Gram-negative bacteria
Read More
Enrollment open in pivotal study of MGN-1703 for metastatic colorectal carcinoma
Read More
DECIDE trial results demonstrate positive benefits for DAC HYP
Read More
Charleston Laboratories updates progress of early-stage programs
Read More
Further funds for Ebola drug development and containment
Read More
Recent FDA orphan drug designations
Read More
New PI3K and mTOR inhibitors disclosed by Calitor Sciences and HEC Pharm
Read More
Pfizer synthesizes novel PDE4 inhibitors
Read More
Allergen divulges novel S1P1 receptor ligands
Read More
Novartis prepares new NEP inhibitors for hypertension and heart failure
Read More
FDA approves Pleximmune to predict transplant rejection in children
Read More
Sangamo plans IND filing next year for use of ZFN-mediated IVPRP in hemophilia B
Read More
Oxygen Biotherapeutics stops phase IIb trial of Oxycyte for traumatic brain injury
Read More
Phase II trial of myostatin-targeted MAb LY-2495655 meets primary objective
Read More
Merck Serono discontinues development of tecemotide as a monotherapy in NSCLC
Read More
Sprint Bioscience's VPS34 inhibitors evaluated as an antitumor strategy
Read More
FDA approves Xtandi for metastatic castration-resistant prostate cancer
Read More
ViaCyte receives accelerated development pathway grant for VC-01
Read More
FDA approves HyQvia for primary immunodeficiency
Read More
FDA advisory committee recommends approval of Natpara for hypoparathyroidism
Read More